New Hope Network is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

ZMC to launch reduced form of CoQ10

ZMC to launch reduced form of CoQ10
ZMC has developed an exclusive IP process unique from any other previous process for manufacturing this ingredient.

Zhejiang Sci-Tech Report, a publication located in Hangzhu, Zhejiang province, China, recently reported Zhejiang Medicine Co. (ZMC) has announced its intention to launch a reduced form of CoQ10. ZMC has stated it has developed an exclusive IP process unique from any other previous process for manufacturing this ingredient. The launch date for the new product is estimated to be in 2013 after completion of the new ZMC production site. No other details were provided but, historically, ZMC’s entrance into the market provides competitive price expectations.

It has been widely reported reduced CoQ10 provides greater bioavailability than the more common oxidized CoQ10. It has been stated the reduced CoQ10 is recommended for patients whose condition requires larger doses of CoQ10.

Hide comments
account-default-image

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish